approval
savePLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: SOLUTION. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 3
same company · ±60 days · 6
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 24, 2022
- approvalRestasis: SANDIMMUNE (CYCLOSPORINE) — FDA approvalMar 16, 2022
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalFeb 4, 2022
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalJan 28, 2022
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalJan 28, 2022
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalJan 28, 2022
comments(0)
5-min edit window · permanent after that